Down 97%, this robotics growth stock has been crushed and is now $3!

Our writer revisits a growth stock that was once a NASDAQ market darling but is now trading for just $3. What on earth has gone wrong?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.

Image source: Getty Images

I’ve been digging into a few former high-flying growth stocks that are now trading very lowly. One that has fallen spectacularly from grace is US consumer robotics firm iRobot (NASDAQ: IRBT).

I mention this because I considered it a few years ago when I wanted to invest in the fast-growing robotics space. Thankfully, I instead went with Intuitive Surgical, the surgical robot pioneer whose shares are up 180% in five years.

I say thankfully because iRobot stock has lost 97% of its value since February 2021. Back then, it peaked at $133, but now trades for less than $4 and has a market cap of just $115m.

Here’s what I’ve learned from iRobot’s demise.

What on earth has happened?

iRobot is famous for its flagship product, the Roomba robotic vacuum cleaner. These little round machines were quite novel a while back. My mate’s puppy used to take a ride on one as it slowly made its way around his front room.

The company also developed a range of other autonomous home cleaning devices, including floor moppers like the Braava series. It was going to launch a robotic lawn mower, but abandoned the project when Covid struck.

In 2021, iRobot reported revenue of $1.56bn and was still profitable. Last year, that had fallen to $682m, with a net loss of $145m. In Q1, its revenue slumped by 32%!

It could have been different though. In 2022, Amazon announced plans to acquire iRobot for $1.7bn. However, the deal was later terminated due to concerns raised by EU competition authorities. Basically, it was feared the acquisition could hinder competition in the robot vacuum cleaner market. 

In hindsight, this appears ironic, given that it’s fierce competition that has been iRobot’s undoing. Specifically, cheaper robot vacuum products from Chinese rivals like Ecovacs Robotics and Roborock have taken over. 

In March, iRobot announced: “Given macroeconomic and tariff-related uncertainties, there is substantial doubt about iRobot’s ability to continue as a going concern“. In other words, it may be heading the way of the dodo!

Alternatively, perhaps the firm will be acquired at a much higher price, creating decent returns for investors brave enough to buy at $3.70. I’m not that brave. though.

The importance of moats

Billionaire investor Warren Buffett once said: “If you’ve got the power to raise prices without losing business to a competitor, you’ve got a very good business. If you have to have a prayer session before raising the price by 10%, then you’ve got a bad business.”

The investing lesson here is that iRobot lacked real brand and pricing power when Chinese competition came flooding in. Many consumers went with the cheaper options, shredding iRobot’s sales and, ultimately, margins.

Returning to Intuitive Surgical, the company is also facing rising competition. So, this is certainly worth me keeping an eye on.

But this is a firm whose moat — a sustainable competitive advantage — still seems incredibly strong to me. There are now over 10,000 of its da Vinci robots in hospitals worldwide. Once surgeons are trained on them, hospitals are very reluctant to switch to rival systems.  

Unfortunately, Intuitive stock is very highly valued today. It’s one I will look to invest more money in during a market meltdown.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Ben McPoland has positions in Intuitive Surgical. The Motley Fool UK has recommended Amazon and Intuitive Surgical. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 ridiculously cheap shares to consider buying now

Harvey Jones can see plenty of cheap shares on the FTSE 100 and says the Iran conflict isn't the main…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

£1,000 buys 1,712 shares in this red hot defence-related penny stock that’s tipped to soar 75%

Edward Sheldon has just spotted a penny stock that appears to offer the winning combination of growth, value, and share…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

£7,500 invested in Aston Martin shares 5 weeks ago is now worth…

With Aston Martin shares down 66% in 13 months and now trading for just 40p each, should I buy the…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

With a P/E ratio of 11, could buying this stock be like investing in Meta Platforms in 2022?

I think Adobe shares today look a lot like Meta stock in October 2022. Could this be another chance for…

Read more »

Investing Articles

Should I wait for the point of maximum panic to buy UK shares?

Harvey Jones is keen to buy cheap UK shares for his Self-Invested Personal Pension. But should he jump in now…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Dividend Shares

The dividend yield of these 2 income stocks just jumped almost 25%

Jon Smith points out an income stock he feels is attractive given the recent share price slump, but also outlines…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Investing Articles

As Rolls-Royce buys its own shares, should I buy more too?

Buying Rolls-Royce shares has been one of James Beard’s best decisions. But is it possible to have too much of…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing For Beginners

Down 43% in a month, what on earth’s going on with the Vistry share price?

Jon Smith points out why the Vistry share price is enduring a tough period, and provides his outlook for the…

Read more »